These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 2214770

  • 1. 7-substituted 1,4,6-androstatriene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
    Li PK, Brueggemeier RW.
    J Steroid Biochem; 1990 Aug 28; 36(6):533-9. PubMed ID: 2214770
    [Abstract] [Full Text] [Related]

  • 2. Synthesis and biochemical studies of 7 alpha-substituted androsta-1,4-diene-3,17-diones as enzyme-activated irreversible inhibitors of aromatase.
    Ebrahimian S, Chen HH, Brueggemeier RW.
    Steroids; 1993 Sep 28; 58(9):414-22. PubMed ID: 8236327
    [Abstract] [Full Text] [Related]

  • 3. Aromatase inhibition by 7-substituted steroids in human choriocarcinoma cell culture.
    Brueggemeier RW, Katlic NE, Kenreigh CA, Li PK.
    J Steroid Biochem Mol Biol; 1992 Jan 28; 41(1):85-90. PubMed ID: 1734938
    [Abstract] [Full Text] [Related]

  • 4. A new hypothesis based on suicide substrate inhibitor studies for the mechanism of action of aromatase.
    Covey DF, Hood WF.
    Cancer Res; 1982 Aug 28; 42(8 Suppl):3327s-3333s. PubMed ID: 7083195
    [Abstract] [Full Text] [Related]

  • 5. Aromatase inhibitors: effect of ring A and ring B unsaturation on aromatase inhibition by 4-thiosubstituted derivatives of 4-androstene-3,17-dione.
    Abul-Hajj YJ, Liu XP, Hedge M.
    Steroids; 1995 May 28; 60(5):423-7. PubMed ID: 7570717
    [Abstract] [Full Text] [Related]

  • 6. Synthesis and biochemical studies of 7-substituted 4,6-androstadiene-3,17-diones as aromatase inhibitors.
    Li PK, Brueggemeier RW.
    J Med Chem; 1990 Jan 28; 33(1):101-5. PubMed ID: 2296006
    [Abstract] [Full Text] [Related]

  • 7. Aromatase inactivation by a suicide substrate, androst-5-ene-4,7,17-trione: the 5beta,6beta-epoxy-19-oxo derivative, as a possible reactive electrophile irreversibly binding to the active site.
    Numazawa M, Tachibana M.
    Biol Pharm Bull; 1997 May 28; 20(5):490-5. PubMed ID: 9178927
    [Abstract] [Full Text] [Related]

  • 8. 7-substituted steroidal aromatase inhibitors: structure-activity relationships and molecular modeling.
    Li PK, Brueggemeier RW.
    J Enzyme Inhib; 1990 May 28; 4(2):113-20. PubMed ID: 2098517
    [Abstract] [Full Text] [Related]

  • 9. Enzyme-generated intermediates derived from 4-androstene-3,6,17-trione and 1,4,6-androstatriene-3,17-dione cause a time-dependent decrease in human placental aromatase activity.
    Covey DF, Hood WF.
    Endocrinology; 1981 Apr 28; 108(4):1597-9. PubMed ID: 7472286
    [Abstract] [Full Text] [Related]

  • 10. Studies directed toward a mechanistic evaluation of aromatase inhibition by androst-5-ene-7,17-dione. Time-dependent inactivation by the 19-nor and 5 beta, 6 beta-epoxy derivatives.
    Numazawa M, Tachibana M.
    Steroids; 1997 Jul 28; 62(7):516-22. PubMed ID: 9253790
    [Abstract] [Full Text] [Related]

  • 11. Novel 19-(cyclopropylamino)-androst-4-en-3,17-dione: a mechanism-based inhibitor of aromatase.
    Njar VC, Düerkop J, Hartmann RW.
    J Enzyme Inhib; 1996 Jul 28; 10(1):47-56. PubMed ID: 8835929
    [Abstract] [Full Text] [Related]

  • 12. 6-Alkylandrosta-4,6-diene-3,17-diones and their 1,4,6-triene analogs as aromatase inhibitors. Structure-activity relationships.
    Numazawa M, Oshibe M, Yamaguchi S.
    Steroids; 1997 Jul 28; 62(8-9):595-602. PubMed ID: 9292934
    [Abstract] [Full Text] [Related]

  • 13. Time-dependent inactivation of aromatase by 6-alkylandrosta-1,4-diene-3,17-diones. Effects of length and configuration of 6-alkyl group.
    Numazawa M, Oshibe M, Yamaguchi S, Tachibana M.
    J Med Chem; 1996 Mar 01; 39(5):1033-8. PubMed ID: 8676338
    [Abstract] [Full Text] [Related]

  • 14. Mechanism for aromatase inactivation by a suicide substrate, androst-4-ene-3,6,17-trione. The 4 beta, 5 beta-epoxy-19-oxo derivative as a reactive electrophile irreversibly binding to the active site.
    Numazawa M, Mutsumi A, Tachibana M.
    Biochem Pharmacol; 1996 Oct 25; 52(8):1253-9. PubMed ID: 8937433
    [Abstract] [Full Text] [Related]

  • 15. Steroidal inhibitors as chemical probes of the active site of aromatase.
    Brueggemeir RW, Moh PP, Ebrahimian S, Darby MV.
    J Steroid Biochem Mol Biol; 1993 Mar 25; 44(4-6):357-65. PubMed ID: 8476749
    [Abstract] [Full Text] [Related]

  • 16. A time-dependent inactivation of aromatase by 19-substituted androst-4-ene-3,6,17-triones.
    Numazawa M, Mutsumi A, Asano N, Ito Y.
    Steroids; 1993 Jan 25; 58(1):40-6. PubMed ID: 8430444
    [Abstract] [Full Text] [Related]

  • 17. Covalent modification of aromatase by a radiolabeled irreversible inhibitor.
    Snider CE, Brueggemeier RW.
    J Steroid Biochem; 1985 Mar 25; 22(3):325-30. PubMed ID: 3990283
    [Abstract] [Full Text] [Related]

  • 18. Thiol-containing androgens as suicide substrates of aromatase.
    Bednarski PJ, Porubek DJ, Nelson SD.
    J Med Chem; 1985 Jun 25; 28(6):775-9. PubMed ID: 4009599
    [Abstract] [Full Text] [Related]

  • 19. Time-dependent aromatase inactivation by 4 beta,5 beta-epoxides of the natural substrate androstenedione and its 19-oxygenated analogs.
    Numazawa M, Yoshimura A, Tachibana M, Shelangouski M, Ishikawa M.
    Steroids; 2002 Mar 25; 67(3-4):185-93. PubMed ID: 11856542
    [Abstract] [Full Text] [Related]

  • 20. Studies of the time-dependent inactivation of aromatase by 4beta,5beta-epoxy-6-one and 5beta,6beta-epoxy-4-one steroids under various conditions.
    Numazawa M, Yamada K.
    Biol Pharm Bull; 1999 Nov 25; 22(11):1207-11. PubMed ID: 10598029
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.